Bio-Rad Laboratories, Inc recalls MRSASelect, IVD, REF 63747, containing 20 plates per package. The MRSASelect is indicated for use in conjunction with o…
- Recall date
- June 8, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1742-2019
- FDA classification
- Class II
- Brand / firm
- Bio-Rad Laboratories, Inc
- Sold / distributed
- US Nationwide Distribution to: AK, AL, AR, AZ, CA, CO, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY, and Puerto Rico.
Why it was recalled
Abnormal coloration of agar plates and the growth of non-characteristic MRSA colonies.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
MRSASelect, IVD, REF 63747, containing 20 plates per package. The MRSASelect is indicated for use in conjunction with other laboratory tests and clinical data available to aid in the identification and diagnosis of MRSA from patients with skin and soft-tissue infections.
Get recall alerts
Free email alert whenever Bio-Rad Laboratories, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Bio-Rad Laboratories, Inc